Takara Bio Inc. (TYO:4974)
Japan
· Delayed Price · Currency is JPY 761.00
-7.00 (-0.91%)
May 22, 2025, 11:28 AM JST
Takara Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 1,997 | 2,853 | 21,224 | 27,532 | 13,552 | Upgrade
|
| Depreciation & Amortization | 4,481 | 5,021 | 4,735 | 4,149 | 3,786 | Upgrade
|
| Loss (Gain) From Sale of Assets | 511 | 551 | 97 | 336 | 97 | Upgrade
|
| Other Operating Activities | -11 | -2,812 | -9,245 | -5,240 | -1,675 | Upgrade
|
| Change in Accounts Receivable | -2,250 | 1,501 | 5,718 | -4,812 | -3,559 | Upgrade
|
| Change in Inventory | 102 | -324 | 13,510 | -14,233 | -1,767 | Upgrade
|
| Change in Accounts Payable | 1,592 | -4,367 | 139 | -431 | 1,016 | Upgrade
|
| Change in Other Net Operating Assets | -578 | -712 | 719 | -316 | 2,493 | Upgrade
|
| Operating Cash Flow | 5,844 | 1,711 | 36,897 | 6,985 | 13,943 | Upgrade
|
| Operating Cash Flow Growth | 241.56% | -95.36% | 428.23% | -49.90% | 119.96% | Upgrade
|
| Capital Expenditures | -9,871 | -12,778 | -5,747 | -12,403 | -8,687 | Upgrade
|
| Sale of Property, Plant & Equipment | 5 | 9 | 396 | 47 | 14 | Upgrade
|
| Cash Acquisitions | -546 | - | - | - | - | Upgrade
|
| Investment in Securities | -94 | 713 | -1,215 | 1,471 | 3,153 | Upgrade
|
| Other Investing Activities | -406 | -987 | -127 | 3,814 | 1,742 | Upgrade
|
| Investing Cash Flow | -10,912 | -13,043 | -6,693 | -7,071 | -3,778 | Upgrade
|
| Dividends Paid | -2,048 | -5,052 | -3,968 | -1,923 | -962 | Upgrade
|
| Other Financing Activities | -208 | -181 | -151 | -147 | -141 | Upgrade
|
| Financing Cash Flow | -2,256 | -5,233 | -4,119 | -2,070 | -1,103 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,190 | 678 | 813 | 1,008 | -215 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 1 | -1 | - | -2 | Upgrade
|
| Net Cash Flow | -6,134 | -15,886 | 26,897 | -1,148 | 8,845 | Upgrade
|
| Free Cash Flow | -4,027 | -11,067 | 31,150 | -5,418 | 5,256 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 123.09% | Upgrade
|
| Free Cash Flow Margin | -8.94% | -25.44% | 39.86% | -8.00% | 11.40% | Upgrade
|
| Free Cash Flow Per Share | -33.44 | -91.91 | 258.69 | -44.99 | 43.65 | Upgrade
|
| Cash Interest Paid | 20 | 22 | 24 | 23 | 24 | Upgrade
|
| Cash Income Tax Paid | -86 | 2,359 | 9,902 | 5,922 | 1,854 | Upgrade
|
| Levered Free Cash Flow | -4,825 | -14,752 | 27,578 | -7,401 | 5,743 | Upgrade
|
| Unlevered Free Cash Flow | -4,813 | -14,737 | 27,593 | -7,386 | 5,758 | Upgrade
|
| Change in Net Working Capital | 837 | 8,857 | -15,767 | 17,196 | -1,938 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.